Back to search

Netherlands· NL-52f844e433a2

Depakine suikervrije stroop, drank 200 mg/5 ml

A valproic acid product containing natriumvalproaat, registered in Netherlands by Euro Registratie Collectief B.V.. The same ATC class is registered in 16 of our 19 countries.

ATC N03AG01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedDepakine suikervrije stroop, drank 20…ATCN03AG01REGISTER NO.NL-52f844e433a2PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Valproic acid is registered in 16 of 19 countries.

Countries holding a registration under ATC N03AG01 (valproic acid), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose

Valproic acid · ATC N03AG01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of valproic acid costs, country by country.

Normalised to the WHO defined daily dose (1.5 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Valproic acid · price per daily dose (1.5 g)

USD · FX 28 Sept 2026

  • CH Switzerland$1.61
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
NATRIUMVALPROAAT
Manufacturer
Euro Registratie Collectief B.V.
Country
Netherlands (NL)
ATC code
N03AG01
ATC class
Valproic acid
Defined daily dose
1.5 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    117561//18153

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

391 interactions on record for valproic acid.

Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Valproic acid · interactions on record

391 records

  • 9 severe
  • 132 moderate
  • 23 minor
  • 189 info

Most severe, free to view

  • Glycerol phenylbutyrateA16AX09severe
  • BexaroteneL01XF03severe
  • VorinostatL01XH01severe
  • BexarotenL01XX25severe

38 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Valproic acid in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All valproic acid products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Austria · Convulex
  • Bulgaria · Convulex, Конвулекс
  • Czechia · Convulex
  • Germany · Convulex
  • Estonia · Convulex
  • United Kingdom (Northern Ireland) · Convulex
  • Hungary · Convulex
  • Lithuania · Convulex
  • Latvia · Convulex
  • Poland · Convulex, Convulex 150
  • Portugal · Ácido Valpróico Generis
  • Romania · Convulex
  • Slovakia · Convulex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1f06166d-97c2-45b9-ab47-e50f01b4779e
GET /v1/drugs/1f06166d-97c2-45b9-ab47-e50f01b4779e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Drank",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h18153_smpc.pdf",
  "strength": null,
  "atc_label": "Valproic Acid",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg117561",
  "excipients": [
    "BENZYLALCOHOL (E 1519)",
    "CITROENZUUR 0-WATER (E 330)",
    "ETHANOL",
    "HYDROXYETHYLCELLULOSE",
    "KERSENSMAAKSTOF IFF 740",
    "METHYLPARAHYDROXYBENZOAAT (E 218)",
    "PONCEAU 4R (E 124)",
    "PROPYLEENGLYCOL (E 1520)",
    "PROPYLPARAHYDROXYBENZOAAT",
    "SACCHAROIDE NATRIUM X-WATER (E 954)",
    "SORBITOL (E 420)",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "NATRIUMVALPROAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h117561.pdf",
  "authorised_at": "2016/05/10",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "117561//18153",
  "additional_monitoring": "Y"
}

See everything about valproic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.